- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07939893
Brief Title: Paracervical Block for Postoperative Pain After Transcervical Procedures Under TIVA
EFFECTIVENESS OF PARACERVICAL BLOCK IN ADDITION TO STANDARD ANALGESIA FOR POSTOPERATIVE PAIN CONTROL FOLLOWING TRANSCERVICAL UTERINE PROCEDURES UNDER TIVA: A RANDOMIZED CONTROLLED TRIAL
Paracervical Block for Postoperative Pain After Transcervical Procedures Under TIVA
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
EFFECTIVENESS OF PARACERVICAL BLOCK IN ADDITION TO STANDARD ANALGESIA FOR POSTOPERATIVE PAIN CONTROL FOLLOWING TRANSCERVICAL UTERINE PROCEDURES UNDER TIVA: A RANDOMIZED CONTROLLED TRIAL
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Zeenat Usman, MS obstetrics and Gyanecology
- Telefonní číslo: +923315333910
- E-mail: usmanbut2@gmail.com
Studijní záloha kontaktů
- Jméno: Quratulain Assosciate Professor, FCPS - Obstetrics and Gynaecol
- Telefonní číslo: +92335587882
- E-mail: qurratulain_saeed@yahoo.com
Studijní místa
-
-
Islamabad
-
Islamabad, Islamabad, Pákistán, 04485
- Pakistan Institute of Medical Sciences (PIMS)
-
Kontakt:
- Zeenat Usman, MS Obstetrics and gyanecology
- Telefonní číslo: +923315333910
- E-mail: qurratulain_saeed@yahoo.com
-
Kontakt:
- Quratulain Associate Professor, FCPS - Obstetrics and Gynaecol
- Telefonní číslo: +92335587882
- E-mail: qurratulain_saeed@yahoo.com
-
Vrchní vyšetřovatel:
- Zeenat Usman, MS obstetrics and gyane
-
Dílčí vyšetřovatel:
- Quratulain Saeed, FCPS - Obstetrics and Gynaecol
-
Dílčí vyšetřovatel:
- Tooba Batool
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Women aged 18 years or older.
- Women scheduled to undergo an eligible transcervical uterine procedure under total intravenous anaesthesia (TIVA).
- Women with stable haemodynamic condition before surgery.
Exclusion Criteria:
- Known allergy or hypersensitivity to lidocaine or other planned local anaesthetic.
- Significant hepatic disease affecting local anaesthetic metabolism.
- Chronic opioid use or chronic pain requiring regular analgesic therapy.
- Major intraoperative complication requiring deviation from the standardized anaesthetic or surgical protocol.
- Patients requiring emergency surgery where informed consent or standardized study procedures cannot safely be completed.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Paracervical Block Plus Standard Analgesia
Participants will receive a standardized paracervical block using lidocaine in addition to standard total intravenous anesthesia (TIVA) and perioperative analgesia for eligible transcervical uterine procedures. Postoperative pain scores and analgesic requirements will be assessed and compared with the control group. |
A standardized paracervical block will be administered after induction of total intravenous anesthesia (TIVA) and before uterine manipulation. The technique will use 2% lidocaine without adrenaline, with 1 mL injected at each of four cervical positions (2, 4, 8, and 10 o'clock), for a total volume of 4 mL (80 mg lidocaine). Aspiration will be performed before and during injection to reduce the risk of intravascular administration. The block will be given in addition to standard TIVA and perioperative analgesia for eligible transcervical uterine procedures. |
|
Žádný zásah: Standard Analgesia Alone
Participants will receive standard total intravenous anesthesia (TIVA) and perioperative analgesia for eligible transcervical uterine procedures without a paracervical block. Postoperative pain scores and analgesic requirements will be assessed and compared with the intervention group. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Postoperative Pain Score (0-10 Visual Analogue Scale [VAS] Score)
Časové okno: From arrival in the recovery area (when awake and able to communicate) to 4 hours post-procedure, assessed at recovery arrival, 30 minutes, 1 hour, 2 hours, and 4 hours where feasible.
|
Postoperative pain intensity will be measured using a 0-10 Visual Analogue Scale (VAS), with 0 representing no pain and 10 representing the worst imaginable pain. The VAS score will be recorded for each participant at recovery room arrival (when awake and able to communicate), 30 minutes, 1 hour, 2 hours, and 4 hours after the procedure, where feasible. The mean or median postoperative pain scores will be compared between participants receiving paracervical block plus standard analgesia and those receiving standard analgesia alone. |
From arrival in the recovery area (when awake and able to communicate) to 4 hours post-procedure, assessed at recovery arrival, 30 minutes, 1 hour, 2 hours, and 4 hours where feasible.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Proportion of Participants Requiring Rescue Analgesia (%)
Časové okno: From completion of the procedure until 4 hours post-procedure.
|
The proportion of participants requiring additional rescue analgesia for postoperative pain despite receiving standard perioperative analgesia will be recorded. Rescue analgesia requirement will be assessed as a binary outcome (Yes/No) using the study Case Report Form (CRF). The percentage of participants requiring rescue analgesia will be compared between the intervention and control groups.Control group is the one receiving standard analgesia that is only TIVA and case group is standard analgesia that is TIVA and paracervical block group |
From completion of the procedure until 4 hours post-procedure.
|
|
Time to First Rescue Analgesia (Minutes)
Časové okno: From completion of the procedure until 4 hours post-procedure
|
Time to first rescue analgesia will be measured in minutes from completion of the transcervical uterine procedure to administration of the first rescue analgesic. The time of administration will be documented using the medication administration record and structured Case Report Form (CRF), and compared between the two study groups. |
From completion of the procedure until 4 hours post-procedure
|
|
Total Postoperative Rescue Analgesic Requirement (Drug-Specific Dose)
Časové okno: From completion of the procedure until 4 hours post-procedure.
|
The total dose of additional rescue analgesic medication administered to each participant for postoperative pain will be recorded using the medication administration record and structured Case Report Form (CRF). The drug name, individual dose and total dose administered during the postoperative observation period will be documented and compared between the two study groups. Results will be expressed in the appropriate drug-specific dose units (e.g., milligrams). |
From completion of the procedure until 4 hours post-procedure.
|
|
Patient Satisfaction Score with Postoperative Pain Management (5-Point Likert Scale)
Časové okno: At the end of the postoperative recovery observation period, up to 4 hours after the procedure.
|
Participant satisfaction with postoperative pain management will be assessed using a predefined 5-point Likert scale recorded on the structured Case Report Form (CRF). The scale ranges from 1 (very dissatisfied), 2 (dissatisfied), 3 (neutral), 4 (satisfied), to 5 (very satisfied). Individual satisfaction scores will be recorded and compared between the two study groups. |
At the end of the postoperative recovery observation period, up to 4 hours after the procedure.
|
|
Time to First Mobilization (Minutes)
Časové okno: From completion of the procedure until first mobilization or discharge from the recovery area, whichever occurs first, within 4 hours post-procedure.
|
Time to first mobilization will be measured in minutes from completion of the transcervical uterine procedure to the participant's first mobilization. The time will be recorded using the structured Case Report Form (CRF) and compared between participants receiving paracervical block plus standard analgesia and those receiving standard analgesia alone. |
From completion of the procedure until first mobilization or discharge from the recovery area, whichever occurs first, within 4 hours post-procedure.
|
|
Incidence of Postoperative Nausea and Vomiting (Number and Percentage of Participants)
Časové okno: From arrival in the recovery area until 4 hours after completion of the procedure.
|
The incidence of postoperative nausea and vomiting will be assessed by recording the presence or absence of nausea and vomiting (Yes/No) using the structured Case Report Form (CRF). The requirement for rescue antiemetic medication will also be documented as Yes or No. Results will be expressed as the number and percentage of participants experiencing nausea and vomiting in each study group. |
From arrival in the recovery area until 4 hours after completion of the procedure.
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Zeenat Usman, MS obstetrics and Gyanecology, SZABMU,PIMS
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- F-5-2/2024(ERRC)30th-PIMS
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Individual participant data collected during this study will not be shared publicly or made available to external researchers. Data will be used by the study investigators for the purposes of the approved research. Participant confidentiality will be maintained in accordance with institutional ethical requirements.
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .